Role of neuronal interferon-γ in the development of myelopathy in rats infected with human T-cell leukemia virus type 1

American Journal of Pathology

Volumn 169, Issue 1, 2006, Pages 189-199

  Miyatake, Yukiko ^a   Ikeda, Hitoshi ^a,b   Ishizu, Akihiro ^a   Baba, Tomohisa ^a   Ichihashi, Toru ^a   Suzuki, Akira ^a   Tomaru, Utano ^a   Kasahara, Masanori ^a   Yoshiki, Takashi ^a,c  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HAKODATE CENTRAL GENERAL HOSPITAL   (Japan)

^c GeneticLab Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GENOMIC DNA; MESSENGER RNA; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 12;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL IMMORTALIZATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA FLANKING REGION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN T CELL LEUKEMIA VIRUS 1; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD DISEASE; VIRUS INFECTION;

EID: 33745714790     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.051225     Document Type: Article

References (49)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980, 77:7415-7419
2. Yoshida M, Miyoshi I, Hinuma Y: Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 1982, 79:2031-2035
3. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de Thé G: Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985, 2:407-410
4. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M: HTLV-I associated myelopathy, a new clinical entity. Lancet 1986, 1:1031-1032
5. Mochizuki M, Watanabe T, Yamaguchi K, Takatsuki K, Yoshimura K, Shirao M, Nakashima S, Mori S, Araki S, Miyata N: HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res 1992, 83:236-239
6. Nishioka K, Maruyama I, Sato K, Kitajima I, Nakajima Y, Osame M: Chronic inflammatory arthropathy associated with HTLV-I. Lancet 1989, 1:441
7. Sugimoto M, Nakashima H, Watanabe S, Uyama E, Tanaka F, Ando M, Araki S, Kawasaki S: T-lymphocyte alveolitis in HTLV-I-associated myelopathy. Lancet 1987, 2:1220
8. Vernant JC, Buisson G, Magdeleine J, De Thore J, Jouannelle A, Neisson-Vernant C, Monplaisir N: T-lymphocyte alveolitis, tropical spastic paresis, and Sjögren syndrome. Lancet 1988, 1:177
9. Morgan OS, Rodgers-Johnson P, Mora C, Char G: HTLV-1 and polymyositis in Jamaica. Lancet 1989, 2:1184-1187
10. LaGrenade L, Hanchard B, Fletcher V, Cranston B, Blattner W: Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet 1990, 336:1345-1347
11. Hollsberg P, Hafler DA: Seminars in medicine of the Beth Israel Hospital, Boston. Pathogenesis of diseases induced by human lymphotropic virus type I infection. N Engl J Med 1993, 328:1173-1182
12. Ishiguro N, Abe M, Seto K, Sakurai H, Ikeda H, Wakisaka A, Togashi T, Tateno M, Yoshiki T: A rat model of human T lymphocyte virus type I (HTLV-I) infection. 1. Humoral antibody response, provirus integration, and HTLV-I-associated myelopathy/tropical spastic paraparesis-like myelopathy in seronegative HTLV-I carrier rats. J Exp Med 1992, 176:981-989
13. Seto K, Abe M, Ohya O, Itakura O, Ishiguro N, Ikeda H, Wakisaka A, Yoshiki T: A rat model of HTLV-I infection: development of chronic progressive myeloneuropathy in seropositive WKAH rats and related apoptosis. Acta Neuropathol (Berl) 1995, 89:483-490
14. Ohya O, Ikeda H, Tomaru U, Yamashita I, Kasai T, Morita K, Wakisaka A, Yoshiki T: Human T-lymphocyte virus type I (HTLV-I)-induced myeloneuropathy in rats: oligodendrocytes undergo apoptosis in the presence of HTLV-I. APMIS 2000, 108:459-466
15. Jacobson S: Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease. J Infect Dis 2002, 186(Suppl 2):S187-S192
16. Kasai T, Ikeda H, Tomaru U, Yamashita I, Ohya O, Morita K, Wakisaka A, Matsuoka E, Moritoyo T, Hashimoto K, Higuchi I, Izumo S, Osame M, Yoshiki T: A rat model of human T lymphocyte virus type I (HTLV-I) infection: in situ detection of HTLV-I provirus DNA in microglia/macrophages in affected spinal cords of rats with HTLV-I-induced chronic progressive myeloneuropathy. Acta Neuropathol (Berl) 1999, 97:107-112
17. Tomaru U, Ikeda H, Ohya O, Abe M, Kasai T, Yamasita I, Morita K, Wakisaka A, Yoshiki T: Human T lymphocyte virus type I-induced myeloneuropathy in rats: implication of local activation of the pX and tumor necrosis factor-alpha genes in pathogenesis. J Infect Dis 1996, 174:318-323
18. Jiang X, Ikeda H, Tomaru U, Morita K, Tanaka Y, Yoshiki T: A rat model for human T lymphocyte virus type I-associated myeloneuropathy. Down-regulation of bcl-2 expression and increase in sensitivity to TNF-alpha of the spinal oligodendrocytes. J Neuroimmunol 2000, 106:105-113
19. Panitch HS, Hirsch RL, Haley AS, Johnson KP: Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1987, 1:893-895
20. Renno T, Taupin V, Bourbonniere L, Verge G, Tran E, De Simone R, Krakowski M, Rodriguez M, Peterson A, Owens T: Interferon-gamma in progression to chronic demyelination and neurological deficit following acute EAE. Mol Cell Neurosci 1998, 12:376-389
21. Krakowski M, Owens T: Interferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur J Immunol 1996, 26:1641-1646
22. Gao X, Gillig TA, Ye P, D'Ercole AJ, Matsushima GK, Popko B: Interferon-gamma protects against cuprizone-induced demyelination. Mol Cell Neurosci 2000, 16:338-349
23. Finke D, Brinckmann UG, ter Meulen V, Liebert UG: Gamma interferon is a major mediator of antiviral defense in experimental measles virus-induced encephalitis. J Virol 1995, 69:5469-5474
24. Patterson CE, Lawrence DM, Echols LA, Rall GF: Immune-mediated protection from measles virus-induced central nervous system disease is noncytolytic and gamma interferon dependent. J Virol 2002, 76:4497-4506
25. Geiger KD, Nash TC, Sawyer S, Krahl T, Patstone G, Reed JC, Krajewski S, Dalton D, Buchmeier MJ, Sarvetnick N: Interferon-gamma protects against herpes simplex virus type 1-mediated neuronal death. Virology 1997, 238:189-197
26. Miyoshi I, Kubonishi I, Yoshimoto S, Akagi T, Ohtsuki Y, Shiraishi Y, Nagata K, Hinuma Y: Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature 1981, 294:770-771
27. Bloch G, Toma DP, Robinson GE: Behavioral rhythmicity, age, division of labor and period expression in the honey bee brain. J Biol Rhythms 2001, 16:444-456
28. Pelidou SH, Zou LP, Deretzi G, Nennesmo I, Wei L, Mix E, Van Der Meide PH, Zhu J: Intranasal administration of recombinant mouse interleukin-12 increases inflammation and demyelination in chronic experimental autoimmune neuritis in Lewis rats. Scand J Immunol 2000, 51:29-35
29. Tomaru U, Ikeda H, Jiang X, Ohya O, Yoshiki T: Provirus expansion and deregulation of apoptosis-related genes in the spinal cord of a rat model for human T-lymphocyte virus type I-associated myeloneuropathy. J Neurovirol 2003, 9:530-538
30. Kroger A, Koster M, Schroeder K, Hauser H, Mueller PP: Activities of IRF-1. J Interferon Cytokine Res 2002, 22:5-14
31. D'Onofrio C, Franzese O, Puglianiello A, Peci E, Lanzilli G, Bonmassar E: Antiviral activity of individual versus combined treatments with Interferon alpha, beta and gamma on early infection with HTLV-I in vitro. Int J Immunopharmacol 1992, 14:1069-1079
32. Neumann H, Schmidt H, Wilharm E, Behrens L, Wekerle H: Interferon gamma gene expression in sensory neurons: evidence for autocrine gene regulation. J Exp Med 1997, 186:2023-2031
33. Olsson T, Kelic S, Edlund C, Bakhiet M, Hojeberg B, van der Meide PH, Ljungdahl A, Kristensson K: Neuronal interferon-gamma immunoreactive molecule: bioactivities and purification. Eur J Immunol 1994, 24:308-314
34. Schmidt B, Stoll G, Toyka KV, Hartung HP: Rat astrocytes express interferon-gamma immunoreactivity in normal optic nerve and after nerve transection. Brain Res 1990, 515:347-350
35. Barish ME, Mansdorf NB, Raissdana SS: Gamma-interferon promotes differentiation of cultured cortical and hippocampal neurons. Dev Biol 1991, 144:412-423
36. Vikman K, Robertson B, Grant G, Liljeborg A, Kristensson K: Interferon-gamma receptors are expressed at synapses in the rat superficial dorsal horn and lateral spinal nucleus. J Neurocytol 1998, 27:749-759
37. Frucht DM, Fukao T, Bogdan C, Schindler H, O'Shea JJ, Koyasu S: IFN-gamma production by antigen-presenting cells: mechanisms emerge. Trends Immunol 2001, 22:556-560
38. Watford WT, Moriguchi M, Morinobu A, O'Shea JJ: The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev 2003, 14:361-368
39. van Rietschoten JG, Smits HH, van de Wetering D, Westland R, Verweij CL, den Hartog MT, Wierenga EA: Silencer activity of NFATc2 in the interleukin-12 receptor beta 2 proximal promoter in human T helper cells. J Biol Chem 2001, 276:34509-34516
40. van Rietschoten JG, Westland R, van den Bogaard R, Nieste-Otter MA, van Veen A, Jonkers RE, van der Pouw Kraan TC, den Hartog MT, Wierenga EA: A novel polymorphic GATA site in the human IL-12Rbeta2 promoter region affects transcriptional activity. Tissue Antigens 2004, 63:538-546
41. Rosenzweig SD, Holland SM: Defects in the interferon-gamma and interleukin-12 pathways. Immunol Rev 2005, 203:38-47
42. Watford WT, Hissong BD, Bream JH, Kanno Y, Muul L, O'Shea JJ: Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol Rev 2004, 202:139-156
43. Xiao BG, Link H: Immune regulation within the central nervous system. J Neurol Sci 1998, 157:1-12
44. Eneroth A, Andersson T, Olsson T, Orvell C, Norrby E, Kristensson K: Interferon-gamma-like immunoreactivity in sensory neurons may influence the replication of Sendai and mumps viruses. J Neurosci Res 1992, 31:487-493
45. Kohanawa M, Nakane A, Asano M, Minagawa T: Theiler's virus is eliminated by a gamma-interferon-independent mechanism in the brain. J Neuroimmunol 1994, 52:79-86
46. Kiefer R, Haas CA, Kreutzberg GW: Gamma interferon-like immunoreactive material in rat neurons: evidence against a close relationship to gamma interferon. Neuroscience 1991, 45:551-560
47. Lau LT, Yu AC: Astrocytes produce and release interleukin-1, interleukin-6, tumor necrosis factor alpha and interferon-gamma following traumatic and metabolic injury. J Neurotrauma 2001, 18:351-359
48. Xiao BG, Link H: IFN-gamma production of adult rat astrocytes triggered by TNF-alpha. Neuroreport 1998, 9:1487-1490
49. Li J, Gran B, Zhang GX, Ventura ES, Siglienti I, Rostami A, Kamoun M: Differential expression and regulation of IL-23 and IL-12 subunits and receptors in adult mouse microglia. J Neurol Sci 2003, 215:95-103